BigHat Biosciences designs safer more effective biologic therapies for patients using machine learning and synthetic biology.
BigHat integrates a wet lab for highspeed characterization with machine learning technologies to guide the search for better antibodies. We apply these design capabilities to develop new generations of safer and more effective treatments for patients suffering from todays most challenging diseases.
BigHat is a Series B biotech outside San Francisco with a teamoriented inclusive and familyfriendly culture. Our broad pipeline of whollyowned and partnered therapeutic programs span many disparate indications with high unmet need such as cancer inflammation and infectious disease. BigHat has raised >$100M from top investors including Section 32 a16z and 8VC.
Disclaimer: Drjobpro.com is only a platform that connects job seekers and employers. Applicants are advised to conduct their own independent research into the credentials of the prospective employer.We always make certain that our clients do not endorse any request for money payments, thus we advise against sharing any personal or bank-related information with any third party. If you suspect fraud or malpractice, please contact us via contact us page.